IGM Biosciences, Inc. (IGMS)

IGM Biosciences Revenue

IGM Biosciences had revenue of $143.62M in the quarter ending June 30, 2025, with 11,353.19% growth. This brings the company's revenue in the last twelve months to $145.05M, up 4,882.82% year-over-year. In the year 2024, IGM Biosciences had annual revenue of $2.68M with 25.77% growth.

• Revenue (ttm): $145.05M
• Revenue Growth: +4,882.82%
• P/S Ratio: 0.55
• Revenue / Employee: $973,490
• Employees: 149
• Market Cap: 78.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.68M	549.00K	25.77%
Dec 31, 2023	2.13M	1.06M	99.25%
Dec 31, 2022	1.07M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.